Loading...
Boceprevir and personalized medicine in hepatitis C virus infection
Boceprevir was the first agent, along with telaprevir, of a novel class of direct-acting antivirals that entered clinical practice for the treatment of chronic hepatitis C. Boceprevir is an antiprotease that directly blocks hepatitis C virus (HCV) replication. Two studies in patients with HCV genoty...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3513234/ https://ncbi.nlm.nih.gov/pubmed/23226068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S24259 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|